UK Markets closed

Atai Life Sciences N.V. (ATAI)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
3.0900-0.0800 (-2.52%)
At close: 01:00PM EST
3.2400 +0.15 (+4.85%)
After hours: 03:54PM EST
Full screen
Trade prices are not sourced from all markets
Previous close3.1700
Bid3.0000 x 800
Ask3.1100 x 1200
Day's range3.0000 - 3.1700
52-week range2.6000 - 11.9200
Avg. volume837,323
Market cap495.321M
Beta (5Y monthly)N/A
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Motley Fool

    New Regulations for Psychedelics? Here's What Investors Need to Know

    If you love investing in businesses that are on the bleeding edge of biotechnology, psychedelics companies are right up your alley. Despite substantial cultural baggage and significant legal hurdles, psychedelic medicines are proving themselves to be highly effective at treating mental illnesses like depression and post-traumatic stress disorder (PTSD), and that means they're likely to be quite lucrative for the developers. On July 13, the Drug Enforcement Agency (DEA) said it was scheduling a public hearing for Aug. 22, so people would have a chance to comment on a proposed rule that would move five psychedelic compounds into the Schedule 1 category.

  • Simply Wall St.

    Here's Why We're Not Too Worried About Atai Life Sciences' (NASDAQ:ATAI) Cash Burn Situation

    We can readily understand why investors are attracted to unprofitable companies. For example, although made...

  • Zacks

    Implied Volatility Surging for ATAI Life Sciences (ATAI) Stock Options

    Investors need to pay close attention to ATAI Life Sciences (ATAI) stock based on the movements in the options market lately.